Citation only
via OpenAlex
Immunity and inflammatory biomarkers in COVID‐19: A systematic review
Ana Paula Diniz Iwamura, Marielen R. Tavares da Silva, Ana Luísa Hümmelgen, Paulo V.S. Pereira, Ângela Falcai, Anete Sevciovic Grumach, Ekaterini Goudouris, Antônio Condino‐Neto, Carolina Prando
Reviews in Medical Virology · 2020 · ▲ 70 citations
Abstract
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database to find the articles related to COVID-19 immunity and inflammatory response published from 1 December 2019 to 15 April 2020. Haematological, immunological and biochemical parameters were extracted and correlated with disease severity, age and presence of comorbidities. Twelve articles were analysed comprising a total of 1042 hospitalized patients infected with SARS-CoV-2 and 95 different parameters. Total lymphocyte count and levels of CD3+ and CD4+ T cells were decreased in severe and critical cases. Neutrophilia was found in patients who progressed to acute respiratory distress syndrome (ARDS). Interleukin-six (IL-6) was high in mild and severe patients regardless of comorbidities. Erythrocyte sedimentation rate (ESR) and count and C-reactive protein (CRP) levels were increased regardless of disease severity or presence of comorbidities. High levels of D-dimer and lactate dehydrogenase were present in diabetic patients and patients who developed ARDS. Procalcitonin levels were elevated to varying degrees in severe and critical patients. We conclude that the total lymphocyte count, CD3+ and CD4+ T cells are low, especially in severe and critical COVID-19 patients; ESR, CRP and IL-6 were elevated, independent of the severity of disease. Understanding the inflammatory response of COVID-19 patients is essential for the development of better therapeutic and management strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/rmv.2199
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Iwamura, A.P.D., Silva, M.R.T.D., Hümmelgen, A.L., Pereira, P.V., Falcai, �., Grumach, A.S., Goudouris, E., Condino‐Neto, A., & Prando, C. (2020). Immunity and inflammatory biomarkers in COVID‐19: A systematic review. <em>Reviews in Medical Virology</em>. https://doi.org/10.1002/rmv.2199
Vancouver
Iwamura APD, Silva MRTD, Hümmelgen AL, Pereira PV, Falcai �, Grumach AS, et al. Immunity and inflammatory biomarkers in COVID‐19: A systematic review. Reviews in Medical Virology. 2020. doi:10.1002/rmv.2199.
BibTeX
@article{ana2020Immuni,
title = {Immunity and inflammatory biomarkers in COVID‐19: A systematic review},
author = {Ana Paula Diniz Iwamura and Marielen R. Tavares da Silva and Ana Luísa Hümmelgen and Paulo V.S. Pereira and Ângela Falcai and Anete Sevciovic Grumach and Ekaterini Goudouris and Antônio Condino‐Neto and Carolina Prando},
journal = {Reviews in Medical Virology},
year = {2020},
doi = {10.1002/rmv.2199},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
American Journal of Hematology 2020
Open access · OA
Hematological findings and complications of <scp>COVID</scp>‐19
Frontiers in Immunology 2021
Open access · CC-BY
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
.مجلة النسور للعلوم الطبية 2022
Citation only
Diagnostic utility of IL-6 and some biomarker correlated with the diseases severity of COVID‐19 patients
Immunity & Ageing 2022
Open access · CC-BY
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
The Egyptian Journal of Neurology Psychiatry and Neurosurgery 2020
Open access · CC-BY
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Clinical Laboratory 2023
Citation only